United States · FDA National Drug Code directory
Guaifenesin Extended-Release 600 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53041-233_8186c3e8-1ae5-459d-8771-ad2d1ae95387
- Product NDC
- 53041-233
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guaifenesin
- Labeler
- Guardian Drug Company
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180301
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (53041-233-30) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 53041-233-30
- 2 BLISTER PACK in 1 CARTON (53041-233-32) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 53041-233-32
- 4 BLISTER PACK in 1 CARTON (53041-233-38) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 53041-233-38
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →